Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis.

Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA.

Am J Epidemiol. 2008 Dec 1;168(11):1221-32. doi: 10.1093/aje/kwn246. Epub 2008 Oct 22. Review. Erratum in: Am J Epidemiol. 2009 May 15;169(10):1280.

2.

Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.

Smith MT, Wang Y, Skibola CF, Slater DJ, Lo Nigro L, Nowell PC, Lange BJ, Felix CA.

Blood. 2002 Dec 15;100(13):4590-3. Epub 2002 Aug 1.

PMID:
12393620
3.

Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.

Lanciotti M, Dufour C, Corral L, Di Michele P, Pigullo S, De Rossi G, Basso G, Leszl A, Luciani M, Lo Nigro L, Micalizzi C, Valsecchi MG, Biondi A, Haupt R.

Leukemia. 2005 Feb;19(2):214-6.

PMID:
15618957
4.

NQO1 rs1800566 (C609T), PON1 rs662 (Q192R), and PON1 rs854560 (L55M) polymorphisms segregate the risk of childhood acute leukemias according to age range distribution.

de Aguiar Gonçalves BA, Vasconcelos GM, Thuler LC, Andrade C, Faro A, Pombo-de-Oliveira MS; Brazilian Collaborative Study Group of Infant Acute Leukemia, Emerenciano M, de Camargo B, Bernstain L, Neves CC, Agareno JM, de Carvalho LM, Araújo FN, de Brito NP, Magalhães IQ, Cordoba JC, Pimenta F, Gadelha A, Cartaxo E, Basegio RM, Mnayarji A, Souza MS, Arencibia A, Melaragno R, Cóser VM, Lafayete TC, Koifman S.

Cancer Causes Control. 2012 Nov;23(11):1811-9. doi: 10.1007/s10552-012-0060-5. Epub 2012 Sep 14.

PMID:
22976839
5.

NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.

Kracht T, Schrappe M, Strehl S, Reiter A, Elsner HA, Trka J, Cario G, Viehmann S, Harbott J, Borkhardt A, Metzler M, Langer T, Repp R, Marschalek R, Welte K, Haas OA, Stanulla M.

Haematologica. 2004 Dec;89(12):1492-7.

6.

NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.

Sirma S, Agaoglu L, Yildiz I, Cayli D, Horgusluoglu E, Anak S, Yuksel L, Unuvar A, Celkan T, Apak H, Karakas Z, Devecioglu O, Ozbek U.

Pediatr Blood Cancer. 2004 Oct;43(5):568-70.

PMID:
15382274
7.

The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan.

Eguchi-Ishimae M, Eguchi M, Ishii E, Knight D, Sadakane Y, Isoyama K, Yabe H, Mizutani S, Greaves M.

Haematologica. 2005 Nov;90(11):1511-5.

8.
9.

Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia.

Infante-Rivard C, Vermunt JK, Weinberg CR.

Am J Epidemiol. 2007 Jun 1;165(11):1248-54. Epub 2007 Mar 1.

10.

The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.

Bolufer P, Collado M, Barragán E, Cervera J, Calasanz MJ, Colomer D, Roman-Gómez J, Sanz MA.

Haematologica. 2007 Mar;92(3):308-14.

11.

Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.

Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT.

Blood. 1999 Jul 15;94(2):803-7.

PMID:
10397748
12.

Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.

Ouerhani S, Cherif N, Bahri I, Safra I, Menif S, Abbes S.

Mol Biol Rep. 2013 Feb;40(2):1307-14. doi: 10.1007/s11033-012-2174-y. Epub 2012 Oct 14.

PMID:
23065291
13.

A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.

Li C, Liu Y, Wei S, Zhou Y.

Pediatr Blood Cancer. 2014 May;61(5):771-7. doi: 10.1002/pbc.24924. Epub 2014 Jan 29.

PMID:
24474393
14.

Prevalence of GSTT1, GSTM1 and NQO1 (609C>T) in Filipino children with ALL (acute lymphoblastic leukaemia).

Rimando MG, Chua MN, Yuson Ed, de Castro-Bernas G, Okamoto T.

Biosci Rep. 2008 Jun;28(3):117-24. doi: 10.1042/BSR20070010.

PMID:
18444911
15.

[Preliminary study on polymorphism of GSTM1, CYP2E1 and NQO1 genes and risk factors of children leukemia].

Wu YX, Gao YJ, Zhao JC, Jing XP, Xia ZL.

Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Sep;25(9):819. Chinese. No abstract available.

PMID:
15555372
16.

Molecular biomarkers for the study of childhood leukemia.

Smith MT, McHale CM, Wiemels JL, Zhang L, Wiencke JK, Zheng S, Gunn L, Skibola CF, Ma X, Buffler PA.

Toxicol Appl Pharmacol. 2005 Aug 7;206(2):237-45. Review.

PMID:
15967214
17.

Study of genetic polymorphism of xenobiotic enzymes in acute leukemia.

Eyada TK, El Ghonemy EG, El Ghoroury EA, El Bassyouni SO, El Masry MK.

Blood Coagul Fibrinolysis. 2007 Jul;18(5):489-95.

PMID:
17581325
18.

Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.

Li C, Zhou Y.

J Cancer Res Clin Oncol. 2014 Jun;140(6):873-81. doi: 10.1007/s00432-014-1595-5. Epub 2014 Feb 2. Review.

PMID:
24488035
19.

Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach.

Binato R, Meyer C, Macedo-Silva ML, Garcia D, Figueiredo A, Hofmann J, Vieira TP, Abdelhay E, Marschalek R.

Cancer Lett. 2013 Sep 28;338(2):249-54. doi: 10.1016/j.canlet.2013.03.029. Epub 2013 Apr 2.

PMID:
23562474
20.

Relatively favorable prognosis for MLL-rearranged childhood acute leukemia with reciprocal translocations.

Yang L, Ding L, Liang J, Chen J, Tang Y, Xue H, Gu L, Shen S, Li B, Chen J.

Pediatr Blood Cancer. 2018 Oct;65(10):e27266. doi: 10.1002/pbc.27266. Epub 2018 Jun 26.

PMID:
29943896

Supplemental Content

Support Center